The COVID-19 pandemic disrupted healthcare and substance use services engagement, including primary and mental health services as well as residential and outpatient drug treatment. Women who inject drugs (WWID) face...
Abstract
Importance Suicidal behavior is a significant clinical concern in individuals with borderline personality disorder (BPD), but the effectiveness of pharmacotherapy on reducing suicide risk has remained unknown.
Objective To...
September 21, 2022, National Center on Substance Abuse and Child Welfare
This webinar features experts from CREOKS Health Services in Oklahoma and Hushabye Nursery in Arizona. Panelists and NCSACW staff highlight the importance of...
Drinking alcohol during pregnancy is associated with Foetal Alcohol Spectrum Disorders (FASD), and women who drink at higher levels are more likely to have a baby with FASD.
Efforts to better understand and respond to ‘high risk’ drinking...
Alcohol and other drug treatment are generally only provided for individuals, often away from their families. Treatment aims to improve well-being and reduce the harms of substance use and families and communities can play a significant...
The May 2023 Preventive Medicine Grand Rounds (PMGR) features Recovery Kentucky, a social model program that provides housing and recovery services for rural Kentuckians dealing with substance use disorder. The program is led by the...
For Immediate Release: May 23, 2023
Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder (OUD)...
